Role of homoeopathy in the treatment of Diabetes Type 2
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2022/04/042114
- Lead Sponsor
- BAKSON HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS WITH GLYCATED HAEMOGLOBIN LEVEL MORE THAN 6.5 AS PER ADA criteria 2021
PATIENTS IN THE AGE GROUP 18 TO 59 YEARS
Exclusion Criteria
Secondary causes of hyperglycemia such as pregnancy, pharmacotherapy such as corticosteroid therapies
Patients who are critically ill and with severe complications like Neuropathy Retinopathy Foot ulcer and other complications of Diabetes and Bedridden patients
Patients with Diabetes type 1
Patients on Insulin Therapy
Lactating females and those who are planning pregnancy
Patient with any psychiatric disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the Glycated Haemoglobin levels towards ImprovementTimepoint: ENROLLMENT PERIOD 5 MONTHS <br/ ><br>FOLLOW UP DURATION 6 MONTHS <br/ ><br>FOLLOW UP EVERY 4 WEEKS <br/ ><br>DATA ANALYSIS 1 MONTH <br/ ><br>TOTAL 12 MONTHS
- Secondary Outcome Measures
Name Time Method Improvement in the quality of lifeTimepoint: ENROLLMENT PERIOD 5 MONTHS <br/ ><br>FOLLOW UP DURATION 6 MONTHS <br/ ><br>FOLLOW UP EVERY 4 WEEKS <br/ ><br>DATA ANALYSIS 1 MONTH <br/ ><br>TOTAL 12 MONTHS